KWR Stock Analysis: Quaker Chemical | NYSE
Specialty Chemicals | NYSE, USA | Market Cap: 2.715m USD | 12M Return: 23.7% | US7473161070 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 22.5M
EPS Trend: -49.0%
Qual. Beats: 1
Rev. Trend: -15.8%
Qual. Beats: 2
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Quaker Chemical Corporation (NYSE: KWR), doing business as Quaker Houghton, is a global supplier of industrial process fluids headquartered in Conshohocken, Pennsylvania, and founded in 1918. The company develops, produces, and markets a broad portfolio of formulated specialty chemical productsincluding metal removal and cleaning fluids, corrosion inhibitors, metal drawing and forming fluids, die cast mold releases, heat treatment quenchants, hydraulic fluids, specialty greases, and rolling lubricants-while also providing chemical management services to heavy industrial and manufacturing customers. Its end markets span steel, aluminum, automotive, aerospace, offshore, container, mining, and metalworking industries, making it a diversified player within the specialty chemicals segment of the broader Materials sector.
- Petrochemical feedstock costs pressure industrial fluid gross margins
- Steel and automotive production volumes drive segment revenue growth
- M&A integration costs and acquisition pipeline shape capital allocation
| Net Income: 97.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -2.20 > 1.0 |
| NWC/Revenue: 29.75% < 20% (prev 32.41%; Δ -2.67% < -1%) |
| CFO/TA 0.05 > 3% & CFO 131.2m > Net Income 97.7m |
| Net Debt (793.6m) to EBITDA (260.1m): 3.05 < 3 |
| Current Ratio: 2.46 > 1.5 & < 3 |
| Outstanding Shares: last quarter (17.3m) vs 12m ago -1.67% < -2% |
| Gross Margin: 34.41% > 18% (prev 36.11%; Δ -1.70% > 0.5%) |
| Asset Turnover: 69.31% > 50% (prev 64.33%; Δ 4.98% > 0%) |
| Interest Coverage Ratio: 3.76 > 6 (EBIT TTM 160.3m / Interest Expense TTM 42.7m) |
| A: 0.21 (Total Current Assets 991.0m - Total Current Liabilities 403.4m) / Total Assets 2.85b |
| B: 0.22 (Retained Earnings 625.6m / Total Assets 2.85b) |
| C: 0.06 (EBIT TTM 160.3m / Avg Total Assets 2.85b) |
| D: 0.94 (Book Value of Equity 1.38b / Total Liabilities 1.47b) |
| Altman-Z'' = 3.43 = A |
| DSRI: 0.98 (Receivables 463.6m/437.4m, Revenue 1.98b/1.83b) |
| GMI: 1.05 (GM 36.11% / 34.41%) |
| AQI: 0.96 (AQ_t 0.52 / AQ_t-1 0.54) |
| SGI: 1.08 (Revenue 1.98b / 1.83b) |
| TATA: -0.01 (NI 97.7m - CFO 131.2m) / TA 2.85b) |
| Beneish M = -2.96 (Cap -4..+1) = A |
As of October 07, 2026, the stock is trading at USD 161.08 with a total of 100,888 shares traded. Over the past week, the price has changed by +1.94%, over one month by +0.15%, over three months by +1.37% and over the past year by +23.73%.
Current recommended Stop Loss: 155.30 (which is 3.6% or 1.3 ATR below the current price).
Quaker Chemical has received a consensus analysts rating of 4.67. Therefore, it is recommended to buy KWR.
- StrongBuy: 4
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 192.6 | 19.5% |
P/E Trailing = 28.2724
P/E Forward = 16.9492
P/S = 1.3743
P/B = 1.9926
P/EG = 1.8561
Revenue TTM = 1.98b USD
EBIT TTM = 160.3m USD
EBITDA TTM = 260.1m USD
Long Term Debt = 857.8m USD (from longTermDebt, last quarter)
Short Term Debt = 15.7m USD (from shortTermDebt, last quarter)
Debt = 948.7m USD (from shortLongTermDebtTotal, last quarter) + Leases 37.6m
Net Debt = 793.6m USD (calculated: Debt 948.7m - CCE 155.1m)
Enterprise Value = 3.51b USD (2.71b + Debt 948.7m - CCE 155.1m)
Interest Coverage Ratio = 3.76 (Ebit TTM 160.3m / Interest Expense TTM 42.7m)
EV/FCF = 38.84x (Enterprise Value 3.51b / FCF TTM 90.3m)
FCF Yield = 2.57% (FCF TTM 90.3m / Enterprise Value 3.51b)
FCF Margin = 4.57% (FCF TTM 90.3m / Revenue TTM 1.98b)
Net Margin = 4.94% (Net Income TTM 97.7m / Revenue TTM 1.98b)
Gross Margin = 34.41% ((Revenue TTM 1.98b - Cost of Revenue TTM 1.30b) / Revenue TTM)
Gross Margin QoQ = 35.53% (prev 36.78%)
Tobins Q-Ratio = 1.23 (Enterprise Value 3.51b / Total Assets 2.85b)
Interest Expense / Debt = 4.50% (Interest Expense 42.7m / Debt 948.7m)
Taxrate = 23.42% (29.9m / 127.7m)
NOPAT = 122.8m (EBIT 160.3m * (1 - 23.42%))
Current Ratio = 2.46 (Total Current Assets 991.0m / Total Current Liabilities 403.4m)
Debt / Equity = 0.69 (Debt 948.7m / totalStockholderEquity, last quarter 1.38b)
Debt / EBITDA = 3.05 (Net Debt 793.6m / EBITDA 260.1m)
Debt / FCF = 8.78 (Net Debt 793.6m / FCF TTM 90.3m)
Total Stockholder Equity = 1.37b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.43% (Net Income 97.7m / Total Assets 2.85b)
RoE = 7.12% (Net Income TTM 97.7m / Total Stockholder Equity 1.37b)
RoCE = 7.19% (EBIT 160.3m / Capital Employed (Equity 1.37b + L.T.Debt 857.8m))
RoIC = 5.19% (NOPAT 122.8m / Invested Capital 2.36b)
WACC = 9.38% (E(2.71b)/V(3.66b) * Re(11.45%) + D(948.7m)/V(3.66b) * Rd(4.50%) * (1-Tc(0.23)))
Discount Rate = 11.45% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -97.37 | Cagr: -1.60%
[DCF] Terminal Value 69.35% ; FCFF base≈115.3m ; Y1≈101.1m ; Y5≈81.7m
[DCF] Fair Price = 19.08 (EV 1.12b - Net Debt 793.6m = Equity 328.4m / Shares 17.2m; r=9.38% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: -48.97 | EPS CAGR: -3.61% | SUE: 3.24 | # QB: 1
Revenue Correlation: -15.79 | Revenue CAGR: -0.51% | SUE: 1.54 | # QB: 2
EPS current Quarter (2026-09-30): EPS=2.10 | Chg30d=-2.63% | Revisions=+67% | Analysts=7
EPS current Year (2026-12-31): EPS=7.87 | Chg30d=+0.13% | Revisions=+70% | GrowthEPS=+12.0% | GrowthRev=+7.6%
EPS next Year (2027-12-31): EPS=9.53 | Chg30d=+0.23% | Revisions=+70% | GrowthEPS=+21.1% | GrowthRev=+4.5%
[Analyst] Revisions Ratio: +87% (up=20, down=0)